SCM
SER icon

Sio Capital Management’s Serina Therapeutics SER Stock Holding History

Sio Capital Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
+1,000,000
New +$2.2M 0.28% 56

Other funds holding SER

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Sio Capital Management's SER Position: Q1 2026 in Review

Sio Capital Management opened a new position in Serina Therapeutics (SER) in Q1 2026: 1,000,000 shares worth $1.94M. The stake represents 0.28% of the portfolio and ranks #56 among its holdings.

25 funds tracked by Wall St. Rank hold SER as of Q1 2026.

  • Sio Capital Management held 1,000,000 shares of Serina Therapeutics worth $1.94M as of Q1 2026.
  • Serina Therapeutics was a new Sio Capital Management position in Q1 2026.
  • Serina Therapeutics made up 0.28% of Sio Capital Management's portfolio in Q1 2026, its #56 holding.
  • 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.